SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
New Stock News | Jiangxi Bio (06915) IPO Subscription period ends with oversubscription of HKD 10.4 billion, 219 times oversubscribed
UBS: Positive on the performance of Chinese AI technology hardware stocks in the second half of the year, next year the volatility may increase.
HK Stock Market Move | Afternoon Surge of over 16% for Nsing Technologies Inc. (02701), the company has the capability to develop CPO-related adaptation, High-speed optical module MCU has been imported and verified.
New Stock News | Jiangxi Bio (06915) IPO Subscription period ends with oversubscription of HKD 10.4 billion, 219 times oversubscribed
UBS: Positive on the performance of Chinese AI technology hardware stocks in the second half of the year, next year the volatility may increase.
HK Stock Market Move | Afternoon Surge of over 16% for Nsing Technologies Inc. (02701), the company has the capability to develop CPO-related adaptation, High-speed optical module MCU has been imported and verified.
RECOMMEND
